HA

Harmony Biosciences

NASDAQ: HRMY

Northbrook, US · Founded 2017 · Delaware corporation · 5 known investors

harmonybiosciences.com ↗

Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases. The company serves patients, families, and advocates in the rare disease community through novel drug development and patient-centered approaches.

Investors · 5

AI

Aisling CapitalNew York

PA

Paragon Biosciences LLCChicago

VA

Valor Equity PartnersChicagovia Antonio Gracias · board

VE

venBio PartnersSan Franciscovia Aaron Royston · board

VI

Vivo CapitalreportedPalo Alto · $10M – $50Mvia Jack Nielsen · board

Competitors · 7

by search overlap

DI

Diabetes Prevention Program111 shared keywords

PA

PatSnap78 shared keywordsPatsnap builds an AI-powered platform for R&D, IP, and innovation intelligence, offering tools for patent search, novelty and FTO analysis, patent drafting, and materials and pharma research. It serves R&D leaders, IP professionals, engineers, and scientists across industries including materials, manufacturing, life sciences, pharmaceuticals, and consumer goods.

FD

Fda49 shared keywords

CO

Cowles_Investments_StemCentrx47 shared keywordsFierce Biotech is a news publication covering the biotechnology, pharmaceutical, and medtech industries, reporting on clinical trials, deals, venture capital, drug development, and research. It serves industry professionals through articles, special reports, events, webinars, and podcasts.

CZ

Czytaj więcej45 shared keywords

NC

NCT0510118738 shared keywords

PR

Precision BioSciences36 shared keywordsPrecision BioSciences is a clinical-stage biotechnology company developing genome-editing therapies based on its ARCUS platform. Note: the page content provided contains only a cookie consent notice, so this description reflects the company's known focus rather than the extracted text.

Companies competing with Harmony Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.